Vertex Pharmaceuticals posted double-digit sales growth in the first-quarter, topping Wall Street expectations, on continued growth of its drug that treats cystic fibrosis. The biotechnology company ...

The S&P MERVAL Index is up 43824.83 points or 3.02% today to 1495826.64 --Up 293157.67 points or 24.38% over the last seven trading days ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

Toronto-listed stocks started the week firmly higher Monday at midday. Sector performance was largely trending higher, with materials, energy and tech stocks leading the gainers. Of the few decliners, ...

U.S. jobs growth could stall in the second half of 2024, with signs of a slowing labor market, according to monthly gauge of employment trends The Conference Board's employment trends index fell to ...

U.S. futures for the S&P 500 were up 0.1% and futures for the Dow Jones Industrial Average rose 0.1%. Changes in futures do not necessarily predict movements after the opening bell. In Europe, the UK ...

Sticky inflation and the Federal Reserve keeping interest rates high may have dimmed the outlook for bond investors, but with ...

Ivanna Hampton: Higher interest rates are sticking around for longer. While Fed Chair Jerome Powell didn’t seem worried about ...

With its 3-star rating, we believe Alphabet’s stock is fairly valued compared with our long-term fair value estimate of $179, ...

Mastercard’s MA first-quarter results show the company is on a steady path and performing roughly in line with its peer Visa ...

The worst-performing ETF in April was the $6.4 billion ARK Innovation ETF, which lost 13.13%. The actively managed ARK ETF ...

Large-blend assets are among the most important building blocks for a diversified portfolio. Over the last 12 months, ...